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Raftvirus type 1 (HIV-1) infection is initiated by successive interactions of viral
envelope glycoprotein gp120 with two cellular surface proteins, CD4 and chemokine receptor. The two most
common chemokine receptors that allow HIV-1 entry are the CCR5 and CXCR4. The CD4 and CCR5 are mainly
localized to the particular plasma membrane microdomains, termed raft, which is rich in glycolipids and
cholesterol. However, the CXCR4 is localized only partially to the raft region. Although the raft domain is
suggested to participate in HIV-1 infection, its role in entry of CXCR4-tropic (X4-tropic) virus is still unclear.
Here, we used a combination of CD4-independent infection system and cholesterol-depletion-inducing
reagent, methyl-β-cyclodextrin (MβCD), to address the requirement of raft domain in the X4-tropic virus
infection. Treatment of CD4-negative, CXCR4-positive human cells with MβCD inhibited CD4-independent
infection of the X4-tropic strains. This inhibitory effect of the cholesterol depletion was observed even when
the CXCR4 was over-expressed on the target cells. Soluble CD4-induced infection was also inhibited by
MβCD. The MβCD had no effect on the levels of cell surface expression of CXCR4. In contrast to these
infections, MβCD treatment did not inhibit CD4-dependent HIV-1 infection in the wild type CD4-expressing
cells. This study and previous reports showing that CD4 mutants localized to non-raft domains function as
HIV-1 receptor indicate that CXCR4 clustering in the raft microdomains, rather than CD4, is the key step for
the HIV-1 entry.
© 2008 Elsevier Inc. All rights reserved.IntroductionHuman immunodeﬁciency virus type 1 (HIV-1) gains entry into
susceptible cells by fusion of the viral membrane with the cell plasma
membrane (Dimitrov, 2000). This process is generally initiated by the
binding of the HIV-1 envelope (Env) glycoprotein gp120 to CD4 on the
host cell surface. The binding then induces conformational change of
the gp120, which allows gp120 to interact with a cellular surface
chemokine receptor, termed coreceptor. HIV-1 can use many types of
chemokine receptors for the entry (Shimizu et al., 2000). The twomost
common types of the coreceptors of the HIV-1 are the CC chemokine
receptor 5 (CCR5) and the CXC chemokine receptor 4 (CXCR4) (Berger
et al., 1999). Successive conformational changes in the gp120 during
these interactions with cellular surface molecules render initially
occluded hydrophobic domain of the envelope gp41 subunit available
to fusion with cellular plasma membrane (Doms, 2000).bo).
l rights reserved.Clustering of multiple CD4 and coreceptor molecules at the site of
the fusion is presumed to be necessary for the efﬁcient fusion of the
viral and host cell membranes (Kuhmann et al., 2000). Because both
the gp120–CD4 and gp120–chemokine receptor associations are
reversible, and because CD4 binding site of the gp120 is conforma-
tionally masked (Kwong et al., 2002), multiple CD4 and chemokine
receptor molecules should almost simultaneously be gathered and
interact with the multiple gp120 at the place of virus–host cell
membrane fusion (Dimitrov 2000; Doms, 2000; Kwong et al., 2002).
Membrane microdomains or lipid rafts are regions of host cell
membrane enriched in glycosphingolipids, sphingomyelin, choles-
terol, glycophosphatidylinositol-anchored proteins, and signaling
proteins (Simons and Ikonen, 1997). The rafts are thought to serve
as sites for recruitment of gp120–gp41–CD4-coreceptor complexes in
a limited area on the cell surface. Increasing evidence indicate such a
scaffolding role of the rafts in HIV-1 entry; (i) HIV-1 infection is
blocked by targeting CD4 to non-raft membrane domains (Del Real
et al., 2002); (ii) membrane raft microdomains mediate lateral
assemblies required for HIV-1 infection (Manes et al., 2000); (iii)
HIV-1 gp120-induced co-clustering of CD4 and coreceptor into the raft
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membrane and the depletion of cholesterol from target cells inhibits
their susceptibility to HIV-1 infection (Manes et al., 2000; Popik et al.,
2002; Liao et al., 2001; Viard et al., 2002). Together with other results,
reported data are compatible with the possibility that the recruitment
of gp120–gp41–CD4-coreceptor complexes into the raft domains is
required for the HIV-1 infection (Liao et al., 2001; Manes et al., 2000;
Popik et al., 2002). However, it is not clear what is the determinant for
the recruitment of the complexes into raft domains.
CD4 (Millan et al., 1999; Manes et al., 2000; Del Real et al., 2002)
and CCR5 (Nguyen and Taub, 2002b; Gaibelet et al., 2006) have been
demonstrated to be present in lipid rafts, and to constitutively interact
each other before the gp120 binding. In contrast, CXCR4 is localized
only partially to the rafts, as evidencedwith partial colocalizationwith
GM1, a raft marker (Manes et al., 2000; Del Real et al., 2002; Nguyen
and Taub, 2002a). It has been reported that a CD4 mutant, which is
localized to non-raft domains of the plasma membrane, blocks HIV-1
entry, indicating that raft localization of CD4 is critical in HIV-1
infection (Del Real et al., 2002). However, more recent studies are
consistent with a possibility that the raft localization of CD4 is not
required for the virus entry (Popik and Alce, 2004; Percherancier et al.,
2003), indicating that CD4 is not the determinant for clustering of
gp120–gp41–CD4–chemokine receptor complexes into raft domains.
Due to the initial localization of CXCR4 in the non-raft region and the
inconsistencies in prior studies, a role of raft domains in CXCR4-tropic
(X4-tropic) HIV-1 entry is not clear yet.
These apparently controversial observations prompted us to
examine the possibility that recruitment of CXCR4 to raft micro-
domains, rather than CD4 raft localization, is the determinant for the
clustering of gp120–gp41–CD4–CXCR4 complexes into raft domains.
To test the possibility, we used HIV-1 pseudotype viruses that have
the X4-tropic Env proteins and can establish infection of CXCR4-
expressing cells without interaction with CD4 (CD4-independent
infection). The viruses were used to infect cells whose cholesterol
were depleted in advancewith treatment by a cholesterol-solubilizing
agent, methyl-β-cyclodextrin (MβCD) (Simons and Ikonen, 1997), and
viral infectivity was measured. We further examined a role of raft
localization of CXCR4 in the HIV-1 entry, as follows. The CD4-
dependent infection induced by soluble CD4 was used to infect
cholesterol-depleted cells. By this approach, we can determine if the
raft localization of CXCR4 is essential in the HIV-1 infections, because
these infections occur independently of CD4 raft localization. Our
results are compatible with the working hypothesis described above
and suggest a supportive role of CD4 in augmenting the raft
recruitment/clustering of CXCR4.
Results
MβCD inhibits CD4-independent, CXCR4-dependent HIV-1 infection
To examine whether raft domain architectures are required for
CD4-dependent and -independent entry of X4-tropic viruses, we
used an infection system of pseudotyped viruses carrying Env
proteins of X4-tropic HIV-1 strains, mNDK, or 8X, that allow
both CD4-dependent and -independent infections in CD4-positive
and -negative cells, respectively (Dumonceaux et al., 1998, Hoffman
et al., 1999, Kubo et al., 2007). As targets of virus infections, we
used human NP2 cells expressing both CD4 and CXCR4, or CXCR4
alone (Soda et al., 1999). The raft domain of target cells were
depleted by the treatment with MβCD (Simons and Ikonen, 1997)
and used for infections of the pseudotyped HIV-1 viruses. As a
control of HIV-1 receptor independent infection, we used the VSV-
G-pseudotyped HIV-1. Incubation with MβCD did not suppress but
rather increased the VSV-G-pseudotyped virus infection (Fig. 1A).
This MβCD treatment (1 and 5 mM) did not affect cell growth (data
not shown).Notably, transduction titers of the HIV-1 vectors having the CD4-
independent Env proteins (mNDK and 8X)were reduced to about 25%
by the increasing concentrations of MβCD treatments of the CD4-
negative, CXCR4-positive cells (Fig. 1B, gray bars, NP2/X4 cells). In
contrast, inhibitory effects of MβCD were less prominent in the CD4-
dependent infections of the same viruses: transduction titers of the
HIV-1 vectors were reduced to about 75% at 5 mM of MβCD (Fig. 1B,
open bars, NP2/CD4/X4 cells). Transduction titer of the HIV-1 vector
having Env protein of the NDK HIV-1 strain, the CD4-dependent
parental strain of the mNDK variant, was not signiﬁcantly inhibited
by MβCD (Fig. 1C). These results show that MβCD inhibits CXCR4-
mediated infection but co-expression of CD4 counteracts the
inhibitory effects. When excess of cholesterol was added, the
inhibitory effect of MβCD on the CD4-independent infection was
abrogated (Fig. 1D), conﬁrming that cholesterol extraction is a
primary cause of suppression of the CD4-independent infection by
MβCD.
To assess if the MβCD treatment indeed had depleted cholesterol
from target cell membranes, cells were stained with the cholesterol-
binding agent, ﬁlipin. Binding of ﬁlipin to cholesterol decreases ﬁlipin
ﬂuorescence at 525 nm (Severs and Robenek, 1983; Castanho et al.,
1992). Fluorescence strength of ﬁlipin in the MβCD-treated cells was
reproductively increased compared to that of the untreated control
cells (Fig. 1E). The results indicate that cholesterol of cell membrane
was indeed extracted byMβCD treatment in our experimental system.
Over-expression of CXCR4 does not affect the inhibitory effect of MβCD
on CD4-independent HIV-1 infection
In our CD4-independent infection system, virus enters into cells
using endogeneously expressed CXCR4. To know whether MβCD still
inhibits infection when cells express exogenously abundant amounts
of CXCR4, human 293T and TE671 cells were transduced by an HA-
tagged CXCR4 encoding murine leukemia virus vector (Kubo et al.,
2003). Over-expression of CXCR4 in the transduced cells was observed
by ﬂow cytometry analysis (Fig. 2A). Transduction titers of the CD4-
independent mNDK vector in the CXCR4-over-expressing cells
increased about 3 to 4 times compared to those in the original cells
(Fig. 2B). This result indicates that CXCR4-over-expression increases
the susceptibility to CD4-independent infection.
Effect of CXCR4-over-expression on the inhibition of CD4-
independent infection by MβCD was analyzed. The MβCD treatment
suppressed the CD4-independent infection in the CXCR4-over-
expressing cells, as it did in the original cells (Fig. 3, upper 4 panels).
However, exogenous introduction of CD4 into the target cells
abrogated the inhibitory effect of MβCD on the HIV-1 infection
(Fig. 3 lower panel), as reported (Viard et al., 2002). The results
indicate that maintenance of the raft domain architectures on the
plasma membrane of the target cells are absolutely required for the
CD4-independent infection and suggest that the raft localization of
CXCR4 is important for the HIV-1 entry. The treatment with MβCD
alone or MβCD plus cholesterol occasionally conferred transduction
titers of the VSV-G and mNDK vectors higher (Figs. 1A, D, and 3). The
mechanism was not understood.
MβCD treatment inhibits CD4-independent HIV-1 Env-mediated
cell-cell fusion
The above result showed that the depletion of cholesterol by MβCD
inhibited the HIV-1 Env-mediated infection. To examine if the
depletion of cholesterol affects the HIV-1 Env-mediated cell-cell
fusion, Env expression plasmid-transfected effector cells and LTR-
LacZ-transfected target cells were co-cultured (see Materials and
methods). The target cells were co-transfected with the Tat expression
and LTR-LacZ plasmids, and then were treated with MβCD. LacZ acti-
vities of the cells were comparable between the cells with andwithout
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treatment does not affect LacZ functional expression. In NP2/CD4/X4
cells, the mNDK Env-mediated cell-cell fusion was not signiﬁcantly
inhibited by MβCD (Fig. 4, NP2/CD4/X4). On the other hand, in CD4-
negative NP2/X4, TE671, and 293T cells, the CD4-independent mNDK
Env-mediated cell–cell fusion was inhibited to 40 to 60% of that in the
untreated cells (Fig. 4, NP2/X4, TE671, and 293 T). The results areFig. 1. Effects of MβCD on HIV-1 infection by different Env protein. (A) Effects of MβCD on
both of CXCR4 and CD4 (NP2/CD4/X4). Cells were treated with 0, 1, 5 mM MβCD for 30 m
vector infection in NP2/X4 and NP2/CD4/X4 cells. Cells were treated with 0, 1, 5 mM MβC
vector in NP2/CD4/X4 cells. (D) Abrogation of MβCD inhibitory effects on mNDK vector i
Relative transduction titers to those in untreated cells are indicated. This experiment was re
signiﬁcant differences compared to their controls. (E) Cholesterol levels in HeLa/CD4 or TE6
ﬂuorescence strength at 525 nm was analyzed by a ﬂow cytometer. Closed area indicates c
and ﬁlipin-stained cells. Gray lines indicate MβCD-treated and ﬁlipin-stained cells.consistent with previous study (Ablan et al., 2006). The cell–cell fusion
activity inhibited by MβCD was recovered, when excess of cholesterol
was added into the culture (Fig. 4, MβCD+chol). The results were
compatible with those of cell-free virus infection (Figs. 1 and 3). Taken
together, our results suggest that cholesterol in the cell membrane
played an important role in the CD4-independent HIV-1 Env-induced
cell–cell fusion and virus entry.VSV-G-pseudotyped vector infection in NP2 cells expressing CXCR4 alone (NP2/X4) or
in at 37 °C. (B) Effects of MβCD on CD4-independent mNDK Env-pseudotyped HIV-1
D for 30 min at 37 °C. (C) Effects of MβCD on the CD4-dependent NDK-pseudotyped
nfection by cholesterol. The cells were pre-treated for 30 min at 37 °C as indicated.
peated three times and results are shown as means+SD. Asterisks indicate statistically
71/CD4 cells after MβCD treatment. MβCD-treated cells were stained with ﬁlipin, and
ells unstained with ﬁlipin as a negative control. Open area indicates MβCD-untreated
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expression levels of CXCR4 in the treated cells were analyzed by a ﬂow
cytometer. Treatment of MβCD did not affect the expression of CXCR4
in NP2/X4, 293 T, and TE671 cells (Fig. 5). This result indicates that the
inhibition of CD4-independent infection by MβCD is not induced by
reducing CXCR4 expression.
Localization of CXCR4 in rafts
The classical way to examine the raft association of membrane
proteins includes treatment of cells with Triton X-100 followed by
Western blot analysis of soluble and insoluble fractions. The fractions
that are not solubilized by Triton X-100 are deﬁned as the raft
membrane domains (Simons and Ikonen, 1997). Using this approach,
we examined localization of CXCR4 in the raft domains in the presence
or absence of MβCD. We also examined raft localization of CD4 as a
maker of raft protein (Manes et al., 2000; Del Real et al., 2002;
Percherancier et al., 2003; Popik and Alce, 2004). CD4 levels in the
insoluble fraction were higher than that in the soluble fraction in all
cells examined (Fig. 6A), suggesting that raft domains were correctly
separated by this protocol. In contrast to CD4, CXCR4 levels in the
insoluble fractions of NP2 and TE671 cells were lower than those in
the soluble fractions. In contrast to these cells, CXCR4 was detected inFig. 2. Effect of CXCR4 overexpression on mNDK HIV-1 vector infection. (A) Cell-surfa
overexpressing cells was analyzed by a ﬂow cytometer using the anti-CXCR4 antibody (A
presence of the A80 antibody, respectively. (B) Relative transduction titers of the VSV-G (o
the original cells are indicated. This experiment was repeated three times and results are s
their controls.the insoluble fraction of 293T cells. CXCR4 was detected in both of
soluble and insoluble fractions after treatment of 293T cells with
MβCD (Fig. 6A), suggesting that CXCR4 is partially transferred to non-
raft domains from raft domains by the MβCD treatment in 293T cells.
However, the transfer of CXCR4 to non-raft domains by the MβCD
treatment in NP2 and TE671 cells was not observed, because majority
of CXCR4 molecules were originally localized to the non-raft domains
in the cells.
To further assess the localization of CXCR4 in the plasma mem-
brane, confocal laser scanning microscopy using the anti-CXCR4
antibody and CT-B was performed. In almost all 293T cells examined,
CXCR4 was co-localized with CT-B, indicating that CXCR4 is largely
localized to the raft domains in the MβCD-untreated 293T cells
(Fig. 6B, the most upper panels). However, the ﬂuorescent signals of
the CXCR4 and CT-B were not matched in about 5% of MβCD-treated
293 T cells (Fig. 6B, the second panels). The data indicate that CXCR4 is
partially transferred to non-raft domains by the MβCD treatment.
In contrast to the 293Tcells, the individual dot signals of CXCR4were
not completely matched to those of CT-B in the almost all TE671 cells
(Fig. 6B, third panel, and arrows in the bottom panel). Interestingly,
when two or more cells came in contact, CXCR4 molecules at cell–cell
adhesion site appeared to be colocalized with CT-B (Fig. 6B bottom
panel). The resultmay imply clusteringof CXCR4 into raft domains at thece expression of CXCR4 in original NP2, 293 T, and TE671 cells and their CXCR4-
80). Closed and open areas indicate the cells that were incubated in the absence and
pen bar) and mNDK (closed bar) vectors in the CXCR4-overexpressing cells to those in
hown as means+SD. Asterisks indicate statistically signiﬁcant differences compared to
27H. Kamiyama et al. / Virology 386 (2009) 23–31cell–cell contact site, and is compatible with previous observations that
contact between HIV-1 Env-expressing and receptor-expressing cells
can induce translocation of CXCR4 from non-raft to raft regions (Manes
et al., 2000; Nguyen et al., 2005), although the CXCR4 localization to raft
domains at cell–cell contact site was independent of HIV-1 Env in our
study. Raft localization of CXCR4 in NP2 cells could not be analyzed,
because CT-B did not bind to NP2 cells. These results of cell-staining
studieswith the293TandTE671 cellswere consistentwith the results of
cell fractionation studies of Fig. 6A.
MβCD inhibits soluble CD4-induced CD4-dependent infection
The MβCD treatment signiﬁcantly inhibited the CD4-indepen-
dent HIV-1 infection, but did not the CD4-dependent infection in the
cells exogenously expressing CD4. To know whether the CD4-
dependent infection does not require raft microdomains of the
target cells, effect of MβCD on soluble CD4 (sCD4)-induced CD4-
dependent infection was analyzed. In this experiment, CD4-
dependent infection occurs independently of CD4 localization to
raft domains. Interestingly, the MβCD treatment signiﬁcantly
inhibited the sCD4-dependent vector (NDK and HXB2) infection
(Fig. 7), indicating that sCD4-induced CD4-dependent infectionFig. 3. Effects of MβCD onmNDKHIV-1 vector infection in CXCR4-overexpressing TE671
and 293T cells. Relative transduction titers of the VSV-G (open bar) and mNDK (closed
bar) vectors in MβCD-treated, CXCR4-overexpressing TE671 and 293 T cells to those in
untreated cells are indicated. Cells were treated with 0, 1, 5 mM MβCD for 30 min at
37 °C. Relative transduction titers to those in untreated cells are indicated. This
experiment was repeated three times and results are shown as means+SD. Asterisks
indicate statistically signiﬁcant differences compared to their controls.requires the raft membrane domains of the target cells. The result
is compatible with the previous report that HIV-1 infection is
inhibited by MβCD in cells expressing a CD4 mutant that is localized
to non-raft domains (Popik and Alce, 2004).
Discussion
The raft domains are thought to participate in versatile biological
events, such as signal transductions and cell–cell communications, as
a scaffold for clustering particular membrane proteins. In this study,
we examined potential roles of the raft in the X4-tropic HIV-1
infections. Previous puzzling observations (Del Real et al., 2002, Popik
and Alce, 2004; Percherancier et al., 2003) prompted us to examine
the possibility that raft localization of CXCR4 rather than CD4 is
primarily required for X4-tropic HIV-1 infection. To avoid complica-
tions of CD4-dependent infection system, we used CD4-independent
or sCD4-induced HIV-1 infection systems.
CD4-independent variants are thought to be prototypes of CD4-
dependent variants, and to show fundamental entry pathway shared
by both CD4-dependent and -independent viruses (Paolo, 2006; Kubo
et al., 2007). Because the CD4-independent and sCD4-induced HIV-1
infections occur independently of CD4 raft localization, they are useful
to study the function of CXCR4 raft localization in HIV-1 infection. The
MβCD treatment signiﬁcantly inhibited the CD4-independent (Fig. 1)
and sCD4-induced CD4-dependent HIV-1 infections (Fig. 7). In
addition, the CXCR4 over-expression did not affect the sensitivity of
CD4-independent infection to the MβCD treatment (Fig. 3). These
results indicate that raft localization of CXCR4 is required for these
HIV-1 infections.
CXCR4 molecules were localized in the raft domains at cell–cell
contact regions, but did not at exposedmembrane regions (Fig. 6). The
HIV-1 vector particles should bind to the CXCR4 molecules in the
exposed cell surface regions, in which CXCR4 is localized to non-raft
domains. How do the CXCR4 molecules present in non-raft domains
function for the X4-tropic HIV-1 infection? It has been already
reported that CXCR4 clusters to raft domains after HIV-1 binding to
the cell surface receptors (Manes et al., 2000; Sorice et al., 2001; Del
Real et al., 2002; Nguyen et al., 2005). Therefore, after the CD4-
independent virus binds to CXCR4 in non-raft domains, the complexes
could move and cluster in the raft domains and induce membrane
fusion for the subsequent viral entry. Alternatively, binding of the
CD4-independent HIV-1 to CXCR4 present in the raft domains, but not
that in the non-raft domains, could induce productive infection.
However, the latter possibility is unlikely, because CXCR4 in raft
domains was detected in the unexposed cell–cell contact sites in
TE671 cells, and NP2 and TE671 cells are as susceptible to the CD4-
independent virus infection as 293T cells, in which CXCR4 is mainly
localized to the raft domains. However, the CD4-independent
infection in 293T cells was suppressed by MβCD as signiﬁcantly as
that in NP2 and TE671 cells. Because CXCR4 is originally localized to
raft domains in 293T cells, the MβCD treatment could inhibit
clustering the raft domains containing CXCR4 molecules in 293T
cells. Taken together, clustering of the CXCR4 in raft domains should
be important for the HIV-1 infection.
Why does the MβCD have no effect on the CD4-dependent
infection in CD4-expressing cells? The lack of prominent inhibitory
effect in our CD4-dependent infection system is compatible with
previous study (Viard et al., 2002). The study showed that MβCD had
no signiﬁcant inhibitory effects on CD4-dependent infectionwhen the
cells expressed exogenously abundant amounts of CD4. One plausible
explanation is that CD4 support the CXCR4 clustering in raft domains
after the HIV-1 binding. The interaction of gp120 to CD4 could induce
signals to recruit CXCR4 to cluster at the virus-binding site by
regulating cytoskeleton dynamics (Iyengar et al., 1998; Viard et al.,
2002; Kubo et al., 2008). It has been reported that the MβCD
treatment slightly decreased cholesterol levels of the target cells (Lu
Fig. 4. Effect of MβCD on HIV-1 Env-mediated fusion. HEK293T effector cells were transfected with the tat or mNDK Env expression plasmid. The mNDK Env expression plasmid is
designated as tat-Env, because it encodes the Tat protein as well as the Env protein. The target cells were transfected with the plasmids and treated by MβCD alone or both of MβCD
and cholesterol as indicated in upper panel. These cells were mixed and LacZ activities of the cell lysates were measured as shown in Materials and methods. Relative values to LacZ
activity of untreated cells were indicated. Asterisks indicate statistically signiﬁcant differences compared to their controls.
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treated cells. Even the partial restriction of raft domains by MβCD
should signiﬁcantly inhibit the CD4-independent infection without
the CD4 support, because certain numbers of the receptor molecules
are required for the infection. Because the sCD4-induced infectionwasFig. 5. Effect of MβCD on CXCR4 expression. Cell-surface expression of CXCR4 in NP2/X4, 2
expression in untreated cells as control, and bottom panels indicate CXCR4 expression in MβC
presence of the A80 antibody, respectively.signiﬁcantly inhibited by MβCD, the cytoplasmic domain-lacking
sCD4 could not induce the signals. Further studies are needed to
clarify this issue.
There are many evidence showing that the HIV-1 gp120–
CD4-coreceptor complexes are clustered in the raft domains. However,93 T, and TE671 cells was analyzed by a ﬂow cytometer. Upper panels indicate CXCR4
D-treated cells. Closed and open areas indicate cells that were incubated in absence and
Fig. 6. Raft localization of CD4 and CXCR4 proteins in the different cells. (A) Cell lysates were prepared fromMβCD-treated and untreated cells with 0.1% Triton X-100, and the soluble
and insoluble fractions are deﬁned as non-raft and raft domains, respectively as shown in Materials and methods. Cell lysates were electrophoresed on 7.5% polyacrylamide gels and
Western blotting was performed using anti-CD4 and anti-HA antibodies. Molecular size standards are indicated on the left side of the panel. Arrows indicate CXCR4 molecules. (B)
CXCR4 expressing cells were cultured on four-well culture slides for 24 h . MβCD-untreated (ﬁrst panel) and treated (second panel) 293T/X4, and untreated TE671/X4 (third and forth
panels) cells were incubated with the rat anti-CXCR4 antibody for 1 h at 4 °C, followed by AlexaFlour 555-conjugated CT-B (red) and FITC-conjugated anti-rat IgG (green) for 1 h at
4 °C. Representative results are shown. The colocalization of red and green gives yellow staining.
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in the raft domains. It has been reported that the CD4 mutants that do
not localize to raft domains can support HIV-1 infection, and the HIV-1
infection through the CD4mutants is sensitive to theMβCD treatment
(Popik and Alce, 2004), indicating that CD4 is not the determinant. It
was found in this study that the MβCD treatment signiﬁcantly inhibits
the CD4-independent X4-tropic HIV-1 infection, even when CXCR4 is
over-expressed in the target cells, indicating that the raft localization of
CXCR4 is absolutely required for the CD4-independent infection. In
addition, the soluble CD4-induced HIV-1 infection was signiﬁcantly
inhibited by the MβCD treatment. These results provide that the raftlocalization of CXCR4, rather than CD4, is one of the key steps for the
HIV-1 entry, and suggest that the interaction between the HIV-1 Env
protein and the wild type CD4 supports the clustering of raft domains
containing CXCR4.
Materials and methods
Env protein expression plasmids
The CD4-independent HIV-1 Env (mNDK strain) and its parental
CD4-dependent HIV-1 Env (NDK strain) expression plasmids were
Fig. 7. Effect of MβCD on soluble CD4-induced CD4-dependent HIV-1 infection. (A) The
HIV-1 vector having the NDKEnv proteinwas inoculated into indicated cells inpresence of
soluble CD4 (sCD4) (20 μg/ml). (B) The HIV-1 vector having the HXB2 Env protein was
inoculated into treatedTE671 cells inpresenceof sCD4.Relative transduction titers to those
in untreated cells are indicated. These experiments were independently repeated three
times. Asterisks indicate statistically signiﬁcant differences compared to their controls.
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independent HIV-1 Env (8X strain) expression plasmid was kindly
provided from Dr. R. Doms (Hoffman et al., 1999). The CD4-dependent
HIV-1 (HXB2 strain) Env expression plasmid was kindly obtained from
Dr. Y. Yokomaku. The VSV-G expression plasmid (pHEF-VSVG) was
obtained from Dr. L. Chang through the AIDS Research and Reference
Reagent Program, Division of AIDS, NIAIS, NIH, USA (Chang et al., 1999).
Cells
Human glioma NP2 (Soda et al., 1999), human rhabdosarcoma
TE671, human cervical cancer HeLa, and human embryonal kidney
(HEK) 293 T cell were cultured in Dulbecco's modiﬁed Eagle's
medium (Sigma) at 37 °C in 5% CO2. The culture media were
supplemented with 8% fetal bovine serum (Bioﬂuids). The original
NP2 cells do not express endogenous CXCR4 and CD4 proteins,
whereas NP2/X4 and NP2/CD4/X4 cells were processed to express
exogenous CXCR4 alone and both of CD4 and CXCR4, respectively
(Soda et al., 1999). TE671/CD4 and 293T/CD4 cells were constructed
as follows. HEK 293T cells were transfected with murine leukemia
virus (MLV) gag–pol (3 μg) (TAKARA), CD4-encoding retroviral vector
(3 μg), and VSV-G expression plasmid (3 μg) (Chang et al., 1999) by
the TransIT LT1 regent (30 μl) (Mirus). The cells were washed 24 h
after transfection, and cultured for 24 h in fresh medium. Culture
supernatant of the transfected cells was inoculated into 293 T or
TE671 cells. The inoculated cells were selected by puromycin (10 μg/
ml). The puromycin-resistant cell pool was utilized in this study.
TE671 and 293 T cells over-expressing CXCR4 were constructed by
transduction of these cells with CXCR4-encoding MLV vector as
described above.Transduction assay
To obtain HIV-1 vector particles containing Env protein, human
293T cells were transfected with a packaging construct of HIV-1
(R8.91) (Naldini et al., 1996), LacZ-containing HIV-1 vector (Iwakuma
et al., 1999), and the appropriate Env expression plasmids (3 μg each)
by the Trans IT-LT1 reagent. The transfected cells were washed with
medium 24 h after transfection, and continued to be cultured in fresh
medium for 24 h . Target cells were inoculated with the culture
supernatants of the transfected cells in presence or absence of soluble
CD4 (20 μg/ml) (obtained from AIDS Research and Reference Reagent
program, NIH). The inoculated cells were stained with 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-Gal) (Wako) 2 days after
inoculation. Blue cells were counted to estimate transduction titer.
Undiluted CD4-independent and -dependent vectors induced usually
around 5×102 and 5×104 blue cells. Therefore, in this study, CD4-
dependent vectors were diluted 100 times with medium.
Cholesterol depletion
The cellswere treatedwithmethyl-β˜cyclodextrin (MβCD) (Sigma) in
FBS-free medium, or with 5mMMβCD and 50 μg/ml cholesterol (Wako)
for 30–120 min at 37 °C. As control, the cells were exposed to FBS-free
medium alone. After incubation, the cells were washed with phosphate
buffer saline (PBS) before being used to remove MβCD and cholesterol.
Filipin staining
The treated cells were ﬁxed with 1% p-formaldehyde in PBS for
10 min at room temperature. The ﬁxed cells were washed and stained
with ﬁlipin (0.1 g/ml) (Sigma) in PBS for 2 h at room temperature.
After washing with PBS, the cells were collected by scraper and
ﬂuorescence strength at 525 nm of the cells was analyzed by a ﬂow
cytometry (Becton Dickinson). Fluorescence strength of ﬁlipin at
525 nm is reduced by its binding to cholesterol (Severs and Robenek,
1983; Castanho et al., 1992).
FACS
To analyze cell surface expression of CXCR4, suspended cells were
treated with a rat anti-CXCR4 antibody (A80) for 1 h at 4 °C. The
CXCR4 antibody (A80) recognizes the third extracellular loop of CXCR4
(Tanaka et al., 2001). The cells werewashedwith PBS 3 times, and then
treated with a FITC-conjugated anti-rat IgG antibody (Sigma). The
stained cells were applied to a ﬂow cytometry (Coulter).
Assay of HIV-1 Env-mediated cell fusion
HEK 293T cells were transfected with the HIV Env expression
plasmid. The plasmid additionally encodes the tat protein. HEK 293T
cells were transfected with a tat expression plasmid as a control.
Target cells were transfected with the LTR-LacZ plasmid, and then
were treated with MβCD. These cells were mixed 48 h after trans-
fection, and cultured for 24 h . LacZ activities of the cell lysates
prepared from the mixed cultures were measured by the high
sensitive β-gal activity measurement kit (Stratagene).
Fractionation of raft membrane microdomains
HA-tagged CXCR4 and CD4 expressing cells werewashed and lysed
on ice by 0.1% Triton X-100. The cell lysates were centrifuged and its
supernatant was deﬁned as soluble fraction. Equal volume of sample
buffer was added to its precipitates, and it was deﬁned as insoluble
fraction. These fractions were subjected to sodium dodecyl sulfate
polyacrylamide gel electrophoresis (10%), and were transferred onto a
PVDFmembrane (Millipore).Western immunoblottingwas performed
31H. Kamiyama et al. / Virology 386 (2009) 23–31using a mouse anti-HA monoclonal (Convance) or anti-CD4 antibody
(Santa Cruz Biotechnology). A horseradish peroxidase-conjugated
anti-mouse IgG antibody (Bio-Red) was used as secondary antibody.
Antibody-binding proteinswere visualized using ECLWestern blotting
detection regents (Amersham Phaemacia Biotech).
Immunoﬂuorescence microscopy
CXCR4 expressing cells were cultured on four-well culture slides
(Miles) for 24 h . Cells were incubated with the rat anti-CXCR4
antibody (A80) for 1 h at 4 °C, followed by AlexaFlour 555-conjugated
CT-B and FITC-conjugated anti-rat IgG for 1 h at 4 °C. Cells were
observed using a confocal ﬂuorescence microscope (Leica).
Statistical analysis
Differences between groups of data were deter,imed by Student's
t-test. Statistical signiﬁcance was set as P b0.01 for all tests.
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